×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ALZN – alzamend neuro, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ALZN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/19
08:32 am
alzn
Alzamend Neuro Announces Completion of Clinical Portion of Phase II Clinical Trial of AL001 "Lithium in Brain" Study Conducted at Massachusetts General Hospital [Yahoo! Finance]
High
Report
Alzamend Neuro Announces Completion of Clinical Portion of Phase II Clinical Trial of AL001 "Lithium in Brain" Study Conducted at Massachusetts General Hospital [Yahoo! Finance]
11/19
08:00 am
alzn
Alzamend Neuro Announces Completion of Clinical Portion of Phase II Clinical Trial of AL001 "Lithium in Brain" Study Conducted at Massachusetts General Hospital
High
Report
Alzamend Neuro Announces Completion of Clinical Portion of Phase II Clinical Trial of AL001 "Lithium in Brain" Study Conducted at Massachusetts General Hospital
11/12
01:24 pm
alzn
Alzamend Neuro (NASDAQ:ALZN) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Alzamend Neuro (NASDAQ:ALZN) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
9/25
08:06 am
alzn
Alzamend Neuro (NASDAQ:ALZN) had its price target lowered by analysts at Ascendiant Capital Markets from $45.00 to $42.00. They now have a "buy" rating on the stock.
Low
Report
Alzamend Neuro (NASDAQ:ALZN) had its price target lowered by analysts at Ascendiant Capital Markets from $45.00 to $42.00. They now have a "buy" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/18
04:31 pm
alzn
Form 8-K Alzamend Neuro, Inc. For: Nov 18
Medium
Report
Form 8-K Alzamend Neuro, Inc. For: Nov 18
10/24
04:30 pm
alzn
Form 4 Alzamend Neuro, Inc. For: Oct 23 Filed by: McGrath Lynne Fahey
Low
Report
Form 4 Alzamend Neuro, Inc. For: Oct 23 Filed by: McGrath Lynne Fahey
10/14
04:52 pm
alzn
Form 8-K Alzamend Neuro, Inc. For: Oct 14
Low
Report
Form 8-K Alzamend Neuro, Inc. For: Oct 14
10/10
04:30 pm
alzn
Form 4 Alzamend Neuro, Inc. For: Oct 08 Filed by: AULT MILTON C III
Medium
Report
Form 4 Alzamend Neuro, Inc. For: Oct 08 Filed by: AULT MILTON C III
10/9
04:30 pm
alzn
Form 8-K Alzamend Neuro, Inc. For: Oct 09
Medium
Report
Form 8-K Alzamend Neuro, Inc. For: Oct 09
10/8
06:51 am
alzn
Form 4 Alzamend Neuro, Inc. For: Oct 03 Filed by: AULT MILTON C III
Low
Report
Form 4 Alzamend Neuro, Inc. For: Oct 03 Filed by: AULT MILTON C III
10/7
09:54 pm
alzn
Form SCHEDULE 13D/A Alzamend Neuro, Inc. Filed by: AULT MILTON C III
Neutral
Report
Form SCHEDULE 13D/A Alzamend Neuro, Inc. Filed by: AULT MILTON C III
10/3
09:37 pm
alzn
Form SCHEDULE 13D/A Alzamend Neuro, Inc. Filed by: AULT MILTON C III
Neutral
Report
Form SCHEDULE 13D/A Alzamend Neuro, Inc. Filed by: AULT MILTON C III
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: